Statistics

Total Visits

Views
Lurbinectedin (PM01183) activity in BRCA1/2-associated or unselected metastatic breast cancer. Interim results of an ongoing phase II trial68

Select a period of time:

Number of views in the range

Views
Lurbinectedin (PM01183) activity in BRCA1/2-associated or unselected metastatic breast cancer. Interim results of an ongoing phase II trial14

Views

Views
May 20250
June 20253
July 20255
August 20253
September 20252
October 20250
November 20251
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States8
United Kingdom2
Brazil2
Chile1
Hong Kong1
 

Top cities views

Views
Dallas4
Gravesend1
Hong Kong1
Paine1
Southampton1
São Vicente1
Visconde do Rio Branco1